NCT06049862Completed
The Effectiveness of "MaRiTensi" in Increasing Self-Care and Blood Pressure Control: Randomized Controlled Trial
"MaRiTensi" SELF MANAGEMENT APPLICATION FOR HYPERTENSION PATIENTS BASED ON M-HEALTH Its Effectiveness In Increasing Self- Care And Controlling Pressure Blood: Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 9 Jul 2024
Brief summary (registry, in English)
This study aims to know the effectiveness of "MaRiTensi" in improving knowledge, motivation, efficacy, self-care and blood pressure control for hypertension patients. This study hypothesizes that MaRiTensi effectively increases the knowledge, motivation, self-efficacy and self-care of hypertensive patients and reduces blood pressure in the intervention group compared to the control group. Respondent recruitment is as follows: 1. The respondent candidate will be identified based on data on record medical 2. Appropriate respondent candidates' criteria inclusion and exclusion contacted for given informed consent 3. Prospective respondents who are willing to participate and fulfill the criteria for pressure blood moment measurement will request signed consent 4. Respondents fill in the basic data and recapitulate by the assistant researcher 5. Done randomization for allocation of group interventions and group control 6. Respondents given envelope closed (using sequentially numbered, opaque sealed envelopes (SNOSE) method ) 7. Respondents' group intervention was given maintenance by Hospital or health center standard-added intervention using MaRiTensi by conditions; meanwhile, group control was provided care by Hospital or health center standards.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 99 (actual)
- First submitted
- 11 Sept 2023
- Start date
- 11 Oct 2023
- Primary completion date
- 28 Apr 2024
- Lead sponsor
- Chatarina Setya Widyastuti
- Diseases
- High blood pressure
- NCT number
- NCT06049862
What you commit to
- Study type: Interventional
- Participants enrolled: 99
- From 11 Oct 2023 to the primary completion date, 28 Apr 2024
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Renal failure (ICD: N17-N19)
- Diabetes Mellitus (ICD: E10-E14.9)
- Stroke (ICD: I60-I69.8)
- Heart Failure (ICD: I50-I50.9)
- Cancer (ICD: C00-C97)
- Dementia (ICD: F00-F04)
- Mental disorders (ICD: F05-F99.9)
- Thyroid Disease (ICD: E00-E07.9)
- Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Syndrome (AIDS) (ICD: B20)
- Movement limitations: Hernia Nucleus Pulposus (HNP) (ICD: M50-M51.9); Piriformis Syndrome (ICD: G57-G57.9); Low Back Pain (LBP) (ICD: M54-M54.9); Frozen Shoulder (ICD: M75-75.9)
Other
- According to the doctor's diagnosis based on ICD 10:
- Acute Miocard Infarction (AMI) (ICD: I21-I21.9)
Who the study is looking for
- A patient registered in the medical record of RSPR, the doctor diagnosed with hypertension based on ICD 10: I10; Age 18 to \<60 years; owning and being able to use a smartphone; living in Yogyakarta during the study period; blood pressure ≥ 140/90 mmHg measured at the time of visit.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Puskesmas Pakem Coordinator of this site? Confirm its status | Sleman | Indonesia | Unknown status |
| Puskesmas Depok 2 Coordinator of this site? Confirm its status | Sleman | Indonesia | Unknown status |
| Panti rapih Hospital Coordinator of this site? Confirm its status | Yogyakarta | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.